Que, Yi
Zhang, Xiao-Long
Liu, Ze-Xian
Zhao, Jing-Jing
Pan, Qiu-Zhong
Wen, Xi-Zhi
Xiao, Wei
Xu, Bu-Shu
Hong, Dong-Chun
Guo, Tian-Hui
Shen, Lu-Jun
Fan, Wei-Jun
Chen, Huo-Ying
Weng, De-Sheng
Xu, Hai-Rong
Zhou, Peng-Hui
Zhang, Yi-Zhuo
Niu, Xiao-Hui
Zhang, Xing https://orcid.org/0000-0003-2665-6940
Clinical trials referenced in this document:
Documents that mention this clinical trial
High transposable element expression in sarcomas is associated with increased immune infiltrates and improved outcomes including after immunotherapy
https://doi.org/10.1136/jitc-2025-012357
590 Metagenomic sequencing reveals unique gut microbial features associated with tertiary lymphoid structures in response to immune checkpoint blockade in solid cancers
https://doi.org/10.1136/jitc-2022-sitc2022.0590
Immunotherapy for sarcomas: new frontiers and unveiled opportunities
https://doi.org/10.1136/jitc-2020-001580
Frequent amplification of HDAC genes and efficacy of HDAC inhibitor chidamide and PD-1 blockade combination in soft tissue sarcoma
https://doi.org/10.1136/jitc-2020-001696
Funding for this research was provided by:
National Scientific Foundation of China (81572403)
National Key Research and Dvelopment Program of China (2017YFA0505600)
National Scientific Foundation of China (81772863)
National Scientific Foundation of China (82002835)